Vaccine
Coronavirus: Moderna sees good results
Sign up now: Get ST's newsletters delivered to your inbox
A key advantage of Moderna's vaccine is that it does not need ultra-cold storage like Pfizer's.
PHOTO: REUTERS
Moderna said yesterday that its experimental vaccine was 94.5 per cent effective in preventing Covid-19, becoming the second US company in a week to report encouraging results.
